Snapshot

The Abridged Review pathway has been developed by the Tanzania Medicines & Medical Devices Authority of Tanzania.

This pathway can be used where This pathway is for WHO-prequalified and SRA-approved products. .

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

When relevant, the agency relies on prior decisions from Australia Brazil Canada China EU-EMA Japan Mexico Rwanda Saudi Arabia Singapore South Korea Switzerland Taiwan (Chinese Taipei) Turkey United Kingdom United States

126